This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Malcolm C. Bateson, MB, MRCP; Frank B. Gibberd, MB, FRCP; Robert S. E. Wilson, MB, MRCP

Arch Neurol. 1973;29(4):274-275.

Abstract
Saliva production was measured in 8 patients with Parkinson disease who complained of drooling, in 9 patients with Parkinson disease and dry mouths, and in 14 controls. No difference was found between the two groups with Parkinson disease. Drooling was not due to excessive salivation but was probably due to defective swallowing. It is not surprising therefore that the majority of drooling patients were not improved with atropine-like drugs.

Author Affiliations
London

From the Department of Neurology, Westminster Hospital Teaching Group, London.

Footnotes
Accepted for publication May 31, 1973.

Reprint requests to the Gordon Hospital, Vauxhall Bridge Road, London S. W. 1 (Dr. Bateson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease
Ondo et al.
Neurology 2004;62:37-40.
ABSTRACT | FULL TEXT